Back to Search Start Over

Differential blood-based biomarkers of subcortical and deep brain small vessel disease.

Authors :
Hervella, Pablo
Alonso-Alonso, Maria Luz
Sampedro-Viana, Ana
Rodríguez-Yáñez, Manuel
López-Dequidt, Iria
Pumar, José M.
Ouro, Alberto
Romaus-Sanjurjo, Daniel
Campos, Francisco
Sobrino, Tomás
Castillo, José
Leira, Yago
Iglesias-Rey, Ramón
Source :
Therapeutic Advances in Neurological Disorders; 5/31/2024, p1-17, 17p
Publication Year :
2024

Abstract

Background: Cerebral small vessel disease is the most common cause of lacunar strokes (LS). Understanding LS pathogenesis is vital for predicting disease severity, prognosis, and developing therapies. Objectives: To research molecular profiles that differentiate LS in deep brain structures from those in subcortical white matter. Design: Prospective case–control study involving 120 patients with imaging-confirmed LS and a 120 control group. Methods: We examined the relationship between Alzheimer's disease biomarkers [amyloid beta (Aβ<subscript>1–40</subscript>, Aβ<subscript>1–42</subscript>)], serum inflammatory marker (interleukin-6, IL-6), and endothelial dysfunction markers [soluble tumor necrosis factor-like weak inducer of apoptosis, and pentraxin-3 (sTWEAK, PTX3)] with respect to LS occurring in deep brain structures and subcortical white matter. In addition, we investigated links between LS, leukoaraiosis presence (white matter hyperintensities, WMHs), and functional outcomes at 3 months. Poor outcome was defined as a modified Rankin scale >2 at 3 months. Results: Significant differences were observed in levels of IL-6, PTX3, and sTWEAK between patients with deep lacunar infarcts and those with recent small subcortical infarcts (20.8 versus 15.6 pg/mL, p < 0.001; 7221.3 versus 4624.4 pg/mL, p < 0.0001; 2528.5 versus 1660.5 pg/mL, p = 0.001). Patients with poor outcomes at 3 months displayed notably higher concentrations of these biomarkers compared to those with good outcomes. By contrast, Aβ<subscript>1–40</subscript> and Aβ<subscript>1–42</subscript> were significantly lower in patients with deep LS (p < 0.0001). Aβ<subscript>1–42</subscript> levels were significantly higher in patients with LS in subcortical white matter who had poor outcomes. WMH severity only showed a significant association with deep LS and correlated with sTWEAK (p < 0.0001). Conclusion: The pathophysiological mechanisms of lacunar infarcts in deep brain structures seem different from those in the subcortical white matter. As a result, specific therapeutic and preventive strategies should be explored. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17562856
Database :
Complementary Index
Journal :
Therapeutic Advances in Neurological Disorders
Publication Type :
Academic Journal
Accession number :
177595485
Full Text :
https://doi.org/10.1177/17562864241243274